Literature DB >> 19063898

Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants.

Ulrich Schroeder1, Alexandra Graff, Sabine Buchmeier, Per Rigler, Unai Silvan, David Tropel, Brigitte M Jockusch, Ueli Aebi, Peter Burkhard, Cora-Ann Schoenenberger.   

Abstract

The role of actin in transcription and RNA processing is now widely accepted but the form of nuclear actin remains enigmatic. Monomeric, oligomeric or polymeric forms of actin seem to be involved in nuclear functions. Moreover, uncommon forms of actin such as the "lower dimer" have been observed in vitro. Antibodies have been pivotal in revealing the presence and distribution of different forms of actin in different cellular locations. Because of its high degree of conservation, actin is a poor immunogen and only few specific actin antibodies are available. To unravel the mystery of less common forms of actin, in particular those in the nucleus, we chose to tailor monoclonal antibodies to recognize distinct forms of actin. To increase the immune response, we used a new approach based on peptide nanoparticles, which are designed to mimic an icosahedral virus capsid and allow the repetitive, ordered display of a specific epitope on their surface. Actin sequences representing the highly conserved "hydrophobic loop," which is buried in the filamentous actin filament, were grafted onto the surface of nanoparticles by genetic engineering. After immunization with "loop nanoparticles," a number of monoclonal antibodies were established that bind to the hydrophobic loop both in vitro and in situ. Immunofluorescence studies on cells revealed that filamentous actin filaments were only labeled once the epitope had been exposed. Our studies indicate that self-assembling peptide nanoparticles represent a versatile platform that can easily be customized to present antigenic determinants in repetitive, ordered arrays and elicit an immune response against poor antigens.

Mesh:

Substances:

Year:  2008        PMID: 19063898     DOI: 10.1016/j.jmb.2008.11.023

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  Modulating adaptive immune responses to peptide self-assemblies.

Authors:  Jai S Rudra; Tao Sun; Katelyn C Bird; Melvin D Daniels; Joshua Z Gasiorowski; Anita S Chong; Joel H Collier
Journal:  ACS Nano       Date:  2012-01-30       Impact factor: 15.881

2.  Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.

Authors:  Xi Zhu; Aleksandar F Radovic-Moreno; Jun Wu; Robert Langer; Jinjun Shi
Journal:  Nano Today       Date:  2014-08-01       Impact factor: 20.722

Review 3.  Nanoscale assemblies and their biomedical applications.

Authors:  Tais A P F Doll; Senthilkumar Raman; Raja Dey; Peter Burkhard
Journal:  J R Soc Interface       Date:  2013-01-09       Impact factor: 4.118

4.  Malaria vaccine based on self-assembling protein nanoparticles.

Authors:  Peter Burkhard; David E Lanar
Journal:  Expert Rev Vaccines       Date:  2015-10-15       Impact factor: 5.217

5.  Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine.

Authors:  Qin Guo; Debleena Dasgupta; Tais A P F Doll; Peter Burkhard; David E Lanar
Journal:  Methods       Date:  2013-03-30       Impact factor: 3.608

Review 6.  α-Helical coiled-coil peptide materials for biomedical applications.

Authors:  Yaoying Wu; Joel H Collier
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-09-06

7.  Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing.

Authors:  Timothy Z Chang; Samantha S Stadmiller; Erika Staskevicius; Julie A Champion
Journal:  Biomater Sci       Date:  2017-01-31       Impact factor: 6.843

8.  A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo.

Authors:  Q Shi; A T Nguyen; Y Angell; D Deng; C-R Na; K Burgess; D D Roberts; F C Brunicardi; N S Templeton
Journal:  Gene Ther       Date:  2010-05-13       Impact factor: 5.250

9.  A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.

Authors:  Stephen A Kaba; Clara Brando; Qin Guo; Christian Mittelholzer; Senthilkumar Raman; David Tropel; Ueli Aebi; Peter Burkhard; David E Lanar
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice.

Authors:  Anshika Tandon; Manisha Pathak; Munesh Kumar Harioudh; Sabahuddin Ahmad; Mohd Sayeed; Tayyaba Afshan; M I Siddiqi; Kalyan Mitra; Shailja M Bhattacharya; Jimut Kanti Ghosh
Journal:  J Biol Chem       Date:  2018-11-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.